Mark Cuban takes on Big Pharma with new venture

Mark Cuban
Photo credit USA TODAY IMAGES

Mavericks owner and billionaire Mark Cuban is taking on big pharma with his latest venture, Mark Cuban Cost Plus Drug Company.

Live On-Air
Ask Your Smart Speaker to Play 10 80 K R L D
NewsRadio 1080 KRLD
Listen Now
Now Playing
Now Playing

The venture spawned from a cold email sent by radiologist Alex Oshmyansky, who was frustrated with the cost of medications and how patients were receiving their prescribed medications. The email got a hugely positive response from Cuban, who then backed the venture.

The company plans to launch an online pharmacy, which will see the 100 most-often prescribed generic prescription drugs. The company plans to be transparent with cost and will tack on a flat 15% margin to the manufacturing price of the drug, plus a $3 dispensing fee. Then will sell that wholesale to pharmacies. The company will then set the suggested retail price.

The company first product will be Albendazole, an antiparasitic drug that sells for around $225 a pill. Patients getting the pill from Mark Cuban Cost Plus would pay $20.

The company will build a plant in Deep Ellum in 2022 which will combine manufacturing, distribution and pharmacy services under one roof.

LISTEN on the Audacy App

Sign Up and Follow NewsRadio 1080 KRLD

Facebook | Twitter

Featured Image Photo Credit: USA TODAY IMAGES